May 16, 2019
In oncology, precision medicine is already well established with targeted therapies approved based on the patient’s genetic makeup or genetic variants of their tumor, and using precision medicine successfully means also using diagnostics and next-generation sequencing (NGS). Last year, CMS finalized coverage of NGS tests, which are to be used to identify patients that may benefit the most from approved treatments. And it looks like other payers may be following CMS’ lead.
May 17, 2018
Former Ambassador Nancy Brinker discusses the future of the Susan G. Komen Foundation stating, "It's time for major innovation."
April 29, 2018
Former Ambassador Nancy Brinker, founder of Susan G. Komen, talks about the stigma that used to surround breast cancer and how she brought awareness to the disease.
April 27, 2018
The president's panel at the American College of Obstetricians and Gynecologists' 2018 Annual Clinical and Scientific Meeting in Austin, Texas, discussed how to make postpartum care more value-based as women give birth at older ages and need team-based care.